Table 3.

Secondary outcomes at month 12

Belatacept (n = 84)CNI (n = 89)
Acute rejection incidence, n (%)6 (7)0
    95% CI1.6 to 12.7
Banff grade, n (%)
    mild acute (IA)1 (1)0
    mild acute (IB)1 (1)0
    moderate acute (IIA)3 (4)0
    moderate acute (IIB)1 (1)0
    severe acute (III)00
Patient/graft survival, n (%)84 (100)88 (99)
    95% CI96.7 to 100.0
Graft loss or death, n (%)01 (1)
    graft loss00
    death01 (1)
    death with functioning graft01 (1)